Losartan Potassium Tablet, Film Coated
Product Images NDC 55154-2326

8 FDA label images from Cardinal Health 107, Llc · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Losartan Potassium (NDC 55154-2326). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Cardinal Health 107, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Losapotatab1 (6cc1d73f 0d63 43bc A54c 6c2295338016 01)

Losapotatab1 (6cc1d73f 0d63 43bc A54c 6c2295338016 01)
Chemical structure of Losartan Potassium showing its molecular components and potassium ion (K+).*
FDA Label Image

Losapotatab2 (6cc1d73f 0d63 43bc A54c 6c2295338016 02)

Losapotatab2 (6cc1d73f 0d63 43bc A54c 6c2295338016 02)
A line graph comparing the percentage of patients with the primary endpoint over study months for Losartan Potassium and Atenolol. The graph shows two lines: a solid line for Losartan Potassium and a dashed line for Atenolol, with Losartan Potassium demonstrating a lower percentage increase over time. It includes an adjusted risk reduction of 13% with a p-value of 0.021.*
FDA Label Image

Losapotatab3 (6cc1d73f 0d63 43bc A54c 6c2295338016 03)

Losapotatab3 (6cc1d73f 0d63 43bc A54c 6c2295338016 03)
A line graph comparing the percentage of patients with fatal or non-fatal stroke over study months between two drugs: Atenolol (dashed line) and Losartan Potassium (solid line). The x-axis shows study months from 0 to 66, and the y-axis shows percentage of patients from 0 to 8%. The graph indicates a lower stroke incidence in patients treated with Losartan Potassium, including an annotation of an adjusted risk reduction of 25% with p=0.001.*
FDA Label Image

Losapotatab (6cc1d73f 0d63 43bc A54c 6c2295338016 04)

Losapotatab (6cc1d73f 0d63 43bc A54c 6c2295338016 04)
A comparative hazard ratio chart displaying the event rates for Losartan-K versus Atenolol in two categories: Primary Composite and Stroke (Fatal/Non-fatal). It breaks down event rates by patient demographics including age, gender, race, presence of ISH, diabetes, and history of cardiovascular disease, showing hazard ratios with 95% confidence intervals to indicate which treatment is favored.*
FDA Label Image

Losapotatab5 (6cc1d73f 0d63 43bc A54c 6c2295338016 05)

Losapotatab5 (6cc1d73f 0d63 43bc A54c 6c2295338016 05)
A line graph comparing the percentage of patients with an event over 48 months between Losartan Potassium Tablet and Placebo groups. The graph shows a lower event rate for Losartan Potassium, indicating a 16.1% risk reduction with a p-value of 0.022.*
FDA Label Image

25mg Bag Label (0a4867c6 B625 44bf Ad89 79eaf2e490df 02)

25mg Bag Label (0a4867c6 B625 44bf Ad89 79eaf2e490df 02)
Losartan Potassium Tablets, USP 25 mg unit dose package label. The label states each tablet contains 25 mg of losartan potassium and includes storage instructions, warnings, prescription status, and distributor information. The package contains 10 tablets and is labeled for institutional use only. Distributed by Cardinal Health and Major Pharmaceuticals.*
FDA Label Image

50mg Bag Label (0a4867c6 B625 44bf Ad89 79eaf2e490df 01)

50mg Bag Label (0a4867c6 B625 44bf Ad89 79eaf2e490df 01)
Losartan Potassium Tablets USP 50 mg film-coated oral tablets package label displaying quantity of 10 tablets. The label includes dosage information, storage instructions to keep at 20°C to 25°C, and warnings about child resistance and institutional use. Packaged by Major Pharmaceuticals and distributed by Cardinal Health.*
FDA Label Image

100mg Bag Label (0a4867c6 B625 44bf Ad89 79eaf2e490df 00)

100mg Bag Label (0a4867c6 B625 44bf Ad89 79eaf2e490df 00)
Losartan Potassium Tablets, USP 100 mg film-coated oral tablets, packaged in a unit dose blister pack containing 10 tablets. The label includes dosage strength, storage instructions (20° to 25°C), and warnings about child resistance and institutional use. Distributed by Cardinal Health 107, LLC, with drug product licensed from Zydus Pharmaceuticals USA.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.